The weekly litigation news digest is live. Subscribe now

IP Verse

Adare Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Adare Pharmaceuticals opposed by its competitors

Explore Adare Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3041476
Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis1
EP2646003
Jun 3, 2020Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods1
EP3403654
Jul 31, 2019Orally Administered Corticosteroid Compositions1
EP2482822
Aug 1, 2018Orally Administered Corticosteroid Compositions1

Latest PTAB cases involving Adare Pharmaceuticals

Discover the latest PTAB cases involving Adare Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adare Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ADARE PHARMACEUTICALS - 4 - -
DR FALK PHARMA1026 -